• 1
    La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001; 10: 1259.
  • 2
    National Cancer Institute of Canada. Canadian cancer statistics 2003. Toronto: The Institute, 2003.
  • 3
    Schildkraut JM. Ovary. In: FrancoEL, RohanTE, eds. Cancer precursors. Epidemiology, detection, and prevention. New York: Springer, 2002. 30420.
  • 4
    Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K. Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years. J Clin Epidemiol 1993; 46: 47587.
  • 5
    Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 1980; 280: 96771.
  • 6
    Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Controls 1996; 7: 497506.
  • 7
    Polychronopoulou A, Tzonou A, Hsieh CC, Kaprinis G, Rebelakos A, Toupadaki N, Trichopoulos D. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors of ovarian cancer. Int J Cancer 1993; 55: 4027.
  • 8
    Hartge P, Schiffman MH, Hoover R, McGown L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989; 161: 106.
  • 9
    Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 1988; 128: 122840.
  • 10
    Franks AL, Lee NC, Kendrick JS, Rubin GL, Layde PM, and the Cancer and Steroid Hormone Study Group. Cigarette smoking and the risk of epithelial ovarian cancer. Am J Epidemiol 1987; 126: 1127.
  • 11
    Baron JA, Byers T, Greenberg ER, Cummings KM, Swanson M. Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst 1986; 77: 67780.
  • 12
    Smith EM, Sowers MF, Burns TL. Effects of smoking on the development of female reproductive cancers. J Natl Cancer Inst 1984; 73: 3716.
  • 13
    Tzonou A, Day NE, Trichopoulos D, Walker A, Saliaraki M, Papapostolou M, Polychronopoulou A. The epidemiology of ovarian cancer in Greece: a case-control study. Eur J Cancer Clin Oncol 1984; 20: 104552.
  • 14
    Terry PD, Miller AB, Jones JG, Rohan TE. Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective study. Eur J Cancer 2003; 39: 115764.
  • 15
    Modugno F, Ness RB, Cottreau CM. Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer. Epidemiology 2002; 13: 46771.
  • 16
    Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Controls 2001; 12: 7139.
  • 17
    Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB. Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 2000; 95: 25560.
  • 18
    Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000; 88: 3138.
  • 19
    Stockwell HG, Lyman GH. Cigarette smoking and the risk of female reproductive cancer. Am J Obstet Gynecol 1987; 157: 3540.
  • 20
    Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124: 45369.
  • 21
    Willett WC. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998.
  • 22
    Health Canada. Nutrient value of some common foods. Ottawa: Public Works and Government Services Canada; 1999.
  • 23
    Jull JW, Streeter DJ, Sutherland L. The mechanism of induction of ovarian tumors in the mouse by 7,12-dimethy-benz[α]anthracene. I. Effect of steroid hormones and carcinogenic concentration in vivo. J Natl Cancer Inst 1966; 37: 40920.
  • 24
    Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1978; 1: 1878.
  • 25
    Zenzes MT, Reed TE, Casper RF. Effects of cigarette smoking and age on the maturation of human oocytes. Hum Reprod 1997; 12: 173641.
  • 26
    Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L. Case-control study of ovarian cancer and polymorphisms in genes involved in catechol estrogen formation and metabolism. Cancer Epidemiol Biomark Prev 2001; 10: 20916.
  • 27
    Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993; 57: 23757.
  • 28
    Shields PG. Epidemiology of tobacco carcinogenesis. Current Oncology Reports 2000; 2: 25762.
  • 29
    Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C[RIGHTWARDS ARROW]A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999; 47: 4459.
  • 30
    Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and α-tocopherol. Pharmacogenetics 1997; 7: 119.
  • 31
    Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, Quinn MA, Green AC. Hormone replacement therapy and risk of epithelial ovarian cancer. Br J Cancer 1999; 81: 55963.
  • 32
    Risch HA, Marrett L, Jain M, Howe GR. Difference in risk factors for epithelial ovarian cancer by histologic type. Am J Epidemiol 1996; 144: 36372.
  • 33
    Risch HA. Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecol Oncol 1996; 63: 2547.
  • 34
    Kvale G, Heuch I, Nilssen S, Beral V. Reproductive factors and risk of ovarian cancer: a prospective study. Int J Cancer 1988; 42: 24651.
  • 35
    World Health Organization. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives. Int J Epidemiol 1987; 18: 53845.
  • 36
    La Vecchia C, Liberati A, Franceschi S. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 1982; 69: 1207.
  • 37
    Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Kolonel LN, Nomura AM, Terada KY, Carney ME, Sobin LH. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003; 158: 62938.
  • 38
    Garner EIO, Stokes EE, Berkowitz RS, Mok SC, Cramer DW. Polymorphisms of the estrogen-metabolizing genes of CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res 2002; 62: 305862.
  • 39
    Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996; 36: 20332.
  • 40
    Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond) 1998; 19: 127.
  • 41
    Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (Lond) 1998; 19: 19437.
  • 42
    Mandai M, Konishi I, Kuroda H, Komatsu T, Yamamoto S, Nanbu K, Matsushita K, Fukumoto M, Yamabe H, Mori T. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. Hum Pathol 1998; 28: 344.